reMYND Driving the development of disease-modifying treatments
We drive the development of disease-modifying treatments against Alzheimers, Parkinsons, Diabetes and other protein misfolding disorders.
OVERVIEW
The site remynd.com presently has a traffic classification of zero (the smaller the more users). We have downloaded eight pages within the web page remynd.com and found four websites interfacing with remynd.com. We were able to precure two contacts and directions for remynd.com to help you connect with them. We were able to precure two mass network sites belong to this website. The site remynd.com has been online for one thousand one hundred and forty-one weeks, seventeen days, seven hours, and twenty-eight minutes.
Pages Parsed
8Links to this site
4Contacts
2Addresses
2Social Links
2Online Since
Mar 2003REMYND.COM TRAFFIC
The site remynd.com is seeing fluctuating amounts of traffic all over the year.
Date Range
1 week
1 month
3 months
This Year
Last Year
All time
Date Range
All time
This Year
Last Year
Date Range
All time
This Year
Last Year
Last Month
REMYND.COM HISTORY
The site remynd.com was first filed on March 07, 2003. This website was changed on the date of April 07, 2011. It will expire on March 07, 2019. It is now one thousand one hundred and forty-one weeks, seventeen days, seven hours, and twenty-eight minutes old.
REGISTERED
March
2003
UPDATED
April
2011
EXPIRED
March
2019
DOMAIN MATURITY
21
YEARS
10
MONTHS
14
DAYS
LINKS TO REMYND.COM
E PHY SCIENCE - In Vivo In Vitro Electrophysiology platform
E-PHY-SCIENCE provides Top level expertise in electrophysiology for both in vivo and in vitro assays. Backed by a Scientific Advisory Board, presided by Pr Lazdunski. And comprised of thought leading experts from industry and academia.
WHAT DOES REMYND.COM LOOK LIKE?
CONTACTS
REMYND.COM SERVER
We caught that a lone root page on remynd.com took seven hundred and fifty-nine milliseconds to download. We could not find a SSL certificate, so in conclusion our crawlers consider remynd.com not secure.
Load time
0.759 sec
SSL
NOT SECURE
IP
148.251.123.139
NAME SERVERS
ns1.3ti.be
ns2.3ti.be
FAVICON
SERVER SOFTWARE
We detected that remynd.com is operating the Apache/2.2.15 (CentOS) os.SITE TITLE
reMYND Driving the development of disease-modifying treatmentsDESCRIPTION
We drive the development of disease-modifying treatments against Alzheimers, Parkinsons, Diabetes and other protein misfolding disorders.PARSED CONTENT
The site had the following in the homepage, "ReMYND drives the development of disease-modifying treatments against protein misfolding disorders." I noticed that the web page stated " ReMYND NV, founded in 2002 as a spin-off from the University of Leuven, drives the development of disease-modifying treatments against Alzheimers." They also stated " And other orphan protein misfolding disorders. reMYND is organized along two independently managed business units, the Contract Research Organization CRO and the own Drug Discovery and Development unit. ReMYNDs own Drug Discovery and Development unit focuse." The meta header had reMynd as the first keyword. This keyword was followed by Contract Research Organization, Drug Discovery and Development, and Diabetes which isn't as important as reMynd. The other words the site uses is TAU model. APP model is also included and will not be understood by search parsers.SEE MORE WEB PAGES
the MOMENT.
Upgrade to paid account! Ohmygod an MLE. Yay, another landscape done in 1. I should go eat now. I see land o o.
remynisce Taking the time to reminisce
Recently my beautiful sister came to visit all the way from Perth, Australia.
Blog de remynouh72 - Blog de remynouh72 - Skyrock.com
Retape dans le champ ci-dessous la suite de chiffres et de lettres qui apparaissent dans le cadre ci-contre.
PersonalPolitical by Remy C.
Monday, January 18, 2010. Hey look I have goth gear! Hmm, well this depen.